Can you provide the consensus estimates for INTELLIGENT BIO SOLUTIONS IN next earnings?
The consensus EPS estimate for the next earnings of INTELLIGENT BIO SOLUTIONS IN (INBS) is 0.14 USD and the consensus revenue estimate is 7.29M USD.
INTELLIGENT BIO SOLUTIONS IN (INBS) Forecast, Price Target & Analyst Ratings
NASDAQ:INBS • US36151G7097
Current stock price
3.24 USD
+0.37 (+12.89%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTELLIGENT BIO SOLUTIONS IN (INBS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q3 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 7.293M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.24 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
INBS was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about INBS.
In the previous month the buy percentage consensus was at a similar level.
INBS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q3 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 7.293M
- Revenue Q2Q
- 900.55%
- EPS Q2Q
- 150.00%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 1.257M 187.49% | 3.112M 147.58% | 3.053M -1.91% | 26.816M 778.49% | |
| EBITDA YoY % growth | -7.622M | -9.309M -22.13% | -9.455M -1.57% | N/A | |
| EBIT YoY % growth | -8.437M -1.19% | -10.283M -21.89% | -10.425M -1.38% | 2.101M 120.15% | |
| Operating Margin | -671.21% | -330.46% | -341.51% | 7.83% | |
| EPS YoY % growth | N/A 51.95% | N/A 95.32% | N/A 96.59% | 0.36 128.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.14 150.00% | 0.34 375.00% |
| Revenue Q2Q % growth | 7.293M 900.55% | 8.966M 962.45% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | 826.2K 132.36% | 1.999M 169.37% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INTELLIGENT BIO SOLUTIONS IN / INBS Forecast FAQ
What is the number of analysts for INBS stock?
The number of analysts covering INTELLIGENT BIO SOLUTIONS IN (INBS) is 7.